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ObjectiveaaThe Structured Interview for Prodromal Syndrome (SIPS) from Yale University is intended to diagnose prodromal syndrome 
of psychosis and to measure the severity of prodromal symptoms. Here, a Korean version of SIPS is presented, and its reliability, validity, and 
factor structures are examined using a representative Korean sample.
MethodsaaThe Korean version of SIPS was administered to 40 participants over a period of 1 year. The inter-rater reliability and internal 
consistency of the SIPS were then evaluated. In addition, its factor structure was investigated using principal-axis factor analysis. Concur-
rent validity was explored using Pearson correlation coefficients with the Positive and Negative Syndrome Scale (PANSS). 
ResultsaaOf the 40 subjects, 12.5% developed psychotic disorders during the 1-year follow-up period. Inter-rater reliability was good (in-
tra-class correlations=0.96), and internal consistency was acceptable (Cronbach’s alpha=0.83). A three-factor resolution displayed the best 
simple structure and accounted for 52.6% of all item variance. Factors 1 and 2 showed strong correlations with negative symptoms and 
cognitive dysfunction, respectively, on the PANSS. Factor 3 was not correlated with any factor on the PANSS.
ConclusionaaThe Korean version of SIPS is a reliable instrument for the assessment of prodromal symptoms in subjects and may be used 
to evaluate prodromal psychosis.  Psychiatry Investig 2010;7:257-263
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INTRODUCTION
Schizophrenia is a common form of chronic mental disor-
der with a lifetime risk of approximately 1%.
1,2 Once symptoms 
are present, it is difficult to return to a pre-morbid state. De-
creased duration of untreated psychosis represents an extreme-
ly important intervention because of reduction in unnecessary 
suffering and possibility to improve long-term outcome.
3,4 For 
these reasons, active involvement in the treatment of psycho-
sis is most beneficial prior to the onset of schizophrenia, i.e., 
in the prodromal state. Rather than ‘prodrome,’ McGorry and 
Singh
5 have suggested that the term ‘at risk mental state’ (AR-
MS) be used to describe a sub-threshold syndrome that can 
be regarded as a risk factor for subsequent psychosis.
To investigate prodromal syndromes and measure the se-
verity of associated symptoms, the Personal Assessment and 
Crisis Evaluation Clinic in Melbourne, Australia, has develop-
ed the Comprehensive Assessment of At-Risk Mental States 
(CAARMS).
6 Similarly, the Prevention through Risk Identifica-
tion, Management, and Education (PRIME) prodromal research 
team at Yale University has developed the Structured Interview 
for Prodromal Syndromes (SIPS).
7 There are some differences 
between these two scales with respect to the criteria for pro-
drome. However, the SIPS provides operational definitions for 
three prodromal syndromes: Brief Intermittent Psychotic Symp-
tom syndrome (BIPS), Attenuated Positive Symptom syndrome 
(APS), and Genetic Risk and Deterioration syndrome (GRD), 
and the CAARMS has similar designations.
BIPS is defined as exhibiting one or more symptoms from 
the positive items on the Scale of Prodromal Symptoms (SOPS) 
in the psychotic range, with the symptom(s) having begun wi-258  Psychiatry Investig 2010;7:257-263
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thin the past 3 months, and exhibiting the symptoms for sev-
eral minutes per day at a frequency of at least once per month. 
Thus, subjects meeting the BIPS criteria display recently emer-
gent, brief, and intermittent psychotic symptoms. APS is char-
acterized by the presence of one or more of the positive items 
on the SOPS scale in the prodromal range, with the symptom(s) 
having appeared within the past year, or showing attenuated 
psychotic symptoms at one or more points within the past year, 
and exhibiting the symptoms at least once per week during the 
past month. These subjects report experiencing mild or at-
tenuated positive symptoms in the form of unusual thought 
content (delusional ideas, persecutory ideas, or grandiose ideas), 
perceptual abnormalities, and disorganized speech. GRD sub-
jects have shown a significant drop in functioning, defined by 
at least a 30% drop in the Global Assessment of Functioning 
(GAF) scale over the past year, and who have a genetic risk in 
the form of a first-degree relative exhibiting any psychotic or 
schizotypal personality disorder. 
The SIPS is a structured diagnostic interview used to diag-
nose the above three prodromal syndromes that was develop-
ed by Miller et al.
8 and McGlashan et al.
9 Several reports have 
confirmed the validity of the SIPS in the diagnosis of prodro-
mal syndrome for psychosis. Miller et al.
7 found the positive 
predictive value to be 50% at 12 months and 67% at 24 months 
among 14 prodromal subjects evaluated using the SOPS. The 
North American Prodrome Longitudinal Study found that, of 
377 prodromal patients who were excluded from GRD status, 
40% converted to a fully psychotic illness during a period of 
30 months.
10 The Prevention Program for Psychosis (P3) report-
ed the conversion rate to psychosis in Spain was 18% and 23% 
at the 1-year and 3-year follow-ups, respectively.
11 These find-
ings suggest that the SIPS might be useful for the diagnosis of 
prodromal syndromes as well as for measuring the severity of 
prodromal symptoms.
Several studies have investigated the reliability and validity 
of the SIPS, but these have only been conducted using the En-
glish and Spanish versions.
7,12 The accurate evaluation of the 
prodromal symptoms of psychosis necessitates appropriate as-
sessment tools that not only utilize the native language, but that 
also consider the language and culture inherent in the instru-
ment. Such tools require validation; thus, a complete Korean 
version of the SIPS was developed. In the present study, the 
usefulness of the Korean version of the SIPS in screening the 
Korean population for prodromal symptoms was assessed 
and its reliability and validity were evaluated.
METHODS
Subjects and clinical interviews
The subjects made initial contact with the Seoul Youth Cli-
nic (SYC) by telephone or through an Internet website (http:// 
neuroimage.snu.ac.kr/youth/index.html). Following a tele-
phone interview by a clinical nurse specialist, a screening in-
terview was conducted by two experienced psychiatrists. Po-
tential subjects ranged from 15 to 33 years of age; patients were 
excluded if they had 1) a past history of medical/neurological 
illness that could manifest as psychiatric symptoms, 2) a histo-
ry of taking antipsychotics/mood stabilizers for longer than 1 
week, or 3) low intelligence (intelligence quotient <70). A total 
of 40 subjects were enrolled in this study.
These subjects were part of a prospective, longitudinal proj-
ect at the SYC from May 2006 to July 2009 that investigated 
individuals with prodromal symptoms of psychosis.
13 The so-
ciodemographic characteristics of the subjects are shown in 
Table 1. Participants had a mean age of 21.33±3.51 years, and 24 
(60%) subjects were male. Individuals were considered pro-
dromal if they met the criteria for at least one of three groups 
at intake: 1) APS, n=31, 2) BIPS, n=0, or 3) GRD, n=6. Three 
subjects met the intake criteria for both the APS and GRD gr-
oups. At intake, all subjects were assessed using the SIPS, Posi-
tive and Negative Syndrome Scale (PANSS),
14 and Structured 
Clinical Interview for DSM-IV.
15 Psychotic features were 
evaluated monthly using the PANSS and at 6 months and 1 
year using the SIPS. Of the 40 subjects who were prodromal at 
baseline, five dropped out, and five developed a psychotic dis-
order. In addition, of the 40 subjects, 15 were taking antipsy-
chotics, 22 were taking antipsychotics and antidepressants, and 
three subjects were not taking medication.
Written informed consent was obtained from all subjects. 
Table 1. Sociodemographic characteristics of subjects (N=40)
Gender (male : female) 24 : 16 
(60% : 40%)
Age (mean±SD, years) 21.33±3.51
Education (mean±SD, years) 13.08±2.07
Group 
Attenuated Positive Prodromal Syndrome (A) 31 (77.5%)
Brief Intermittent Psychotic Symptom Syndrome 0 (0%)0.
Genetic Risk and Deterioration Prodromal 
  Syndrome (G)
6 (15%).
Both A and G 3 (7.5%)
Result of follow up
Conversion to psychosis 05 (12.5%)
Drop out 05 (12.5%)
History of medications
Antipsychotics only  15 (37.5%)
Combination of antipsychotics and 
  antidepressants 
22 (55%)0.
None  3 (7.5%)MH Jung et al. 
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Parental consent was obtained for subjects younger than 18 
years of age. This study was approved by the Institutional Review 
Board at Seoul National University Hospital, Seoul, Korea.
Assessment instruments
Structured Interview for Prodromal Syndrome
The SIPS includes the SOPS, the Schizotypal Personality Dis-
order Checklist,
16 a family history questionnaire,
17 and a modi-
fied version of the GAF.
18 In addition, the SIPS contains oper-
ational definitions of the three prodromal syndromes (Criteria 
of Prodromal Syndromes) and psychosis onset (Presence of Psy-
chotic Syndrome). The SOPS is a 19-item scale designed to 
measure the severity of prodromal symptoms and is compos-
ed of four subscales for five attenuated positive symptoms, six 
negative symptoms, four disorganization symptoms, and four 
general symptoms. The seven-point scales cover severity of 
symptoms for the attenuated psychotic range and other symp-
toms. The seven-point scales used to score each item assess the 
severity of symptoms for the attenuated psychotic range as well 
as other symptoms. The positive symptoms rated on the SOPS 
are one aspect of a prodromal diagnosis, whereas the negative, 
disorganization, and general symptoms rated on the SOPS are 
helpful to evaluate the overall severity of symptoms once the 
diagnosis is established. The SOPS is analogous to the PANSS 
and the Brief Psychiatric Rating Scale, although the latter two 
instruments are severity rating scales used for patients who are 
fully psychotic rather than for those who are sub-psychotic or 
show attenuated symptoms. 
With the permission of the author (Thomas H. McGlashan), 
three experienced psychiatrists translated the SIPS (version 
3.1) into Korean. The Korean version of SIPS was then back-tr-
anslated by a bilingual individual, and modifications were 
made. The final version was reviewed by the original translators.
Positive and Negative Syndrome Scale
The PANSS is a 30-item scale used to measure symptom se-
verity for patients with schizophrenia and is composed of th-
ree subscales: the positive symptoms (7 items, including delu-
sions and hallucinations), negative symptoms (7 items, in-
cluding blunted affect and social withdrawal), and general psy-
chopathology (14 items for general symptoms, including an-
xiety and depression) scales. Each of the items is scored on a 
7-point Likert-type scale (1=absent and 7=extreme) represent-
ing increasing levels of psychopathology. The Korean version 
of PANSS has demonstrated good concurrent validity with 
other scales and inter-rater and test-retest reliability.
14
Statistical analyses
SPSS software for Windows (version 12; SPSS Inc, Chicago, IL, 
USA) was used for statistical analyses.
RESULTS
The mean ratings for the SOPS subscale were 2.03 for posi-
tive symptoms, 1.93 for negative symptoms, 1.14 for disorganiz-
ed symptoms, and 2.13 for general symptoms. Of the 19 symp-
toms featured, 16 had means below the total-scale midpoint 
of 3.0 (Table 2). For three symptoms, grandiosity, impairment 
in personal hygiene or social attentiveness, and motor disturb-
ances, most subjects (≥70%) were rated as displaying no pa-
thology.
 
Reliability
Inter-rater reliability
Two psychiatrists independently rated 20 cases, and the 
inter-rater reliability of the Korean version of SOPS scores was 
evaluated using the Intraclass Correlations Coefficient.
19 The 
inter-rater reliability of the SOPS total score was 0.96 and those 
of four subscales (positive, negative, disorganization, and gen-
eral symptoms) were 0.84, 0.97, 0.86, and 0.92, respectively. 
Thus, inter-rater reliability was in the excellent range for the 
total score and for all subscales.
20
Internal consistency 
The Cronbach’s alpha coefficient for the SOPS total score 
was 0.83, with an alpha level of 0.50 for the positive symptoms 
subscale, 0.78 for the negative symptoms subscale, 0.56 for 
the disorganization symptoms subscale, and 0.48 for the gen-
eral symptoms subscale.
21 
Validity
Factor analysis
Principal axis factor analysis was employed to explore the 
factor structures of the Korean version of SOPS. The initial 
exploratory factor analysis used an oblique (promax) rotation 
and generated six factors with eigenvalues greater than one. 
The number of factors was determined based on 1) a scree 
test,
22 2) the interpretability of the factor structures,
23 3) model 
fit indices,
24 and 4) Thurstone’s criteria.
25 These criteria require 
a minimum number of items with salient loadings (≥0.30) on 
more than one factor, a minimum number of items that do not 
have salient loadings on any factor, and a minimum number of 
items having three or more salient loadings per factor. Based on 
these criteria, a three-factor resolution displayed the best sim-
ple structure and accounted for 52.6% of the all item variance 
(Table 3). Taking salient loadings as those ≥0.30, Factor 1 had 
five of the six SOPS negative symptoms (the exception was ‘de-260  Psychiatry Investig 2010;7:257-263
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creased ideational richness’). Two disorganization symptoms, 
including ‘bizarre thinking’ and ‘trouble with focus and atten-
tion,’ loaded onto Factor 1 along with ‘perceptual abnormali-
ties/hallucination’ and ‘suspiciousness/persecutory ideas.’ Two 
disorganized symptoms as well as ‘disorganized communica-
tion’ (classified as a positive symptom in SOPS) loaded on Fac-
tor 2. In addition, two general symptoms, ‘motor disturbances’ 
and ‘sleep disturbance,’ loaded on Factor 2 along with ‘unusual 
thought content/delusional ideas.’ Finally, a positive symptom, 
‘grandiosity,’ a negative symptom, ‘decreased ideational rich-
ness,’ and two general symptoms, ‘impaired tolerance to normal 
stress’ and ‘dysphoric mood,’ loaded on Factor 3.
Concurrent validity
To evaluate the concurrent validity of the Korean version of 
SIPS, a Pearson’s correlation analysis was performed between 
each SOPS sub-scores (the three factors extracted in the pres-
ent study) and the five factors of the PANSS that have been not-
ed in previous studies.
14,26 PANSS factors included cognitive 
dysfunction, excitement, depression, positive symptoms, and 
negative symptoms. A Bonferroni correction placed signific-
ance at p=0.006. Factor 1 was significantly correlated with ne-
gative symptoms (r=0.72, p<0.001), cognitive dysfunction (r= 
0.61, p<0.001), positive symptoms (r=0.43, p<0.005), and PA-
NSS total score (r=0.53, p<0.001)(Table 4). Factor 2 was signifi-
cantly associated with cognitive dysfunction (r=0.70, p<0.001), 
negative symptoms (r=0.51, p<0.005), positive symptoms (r= 
0.47, p<0.005), and PANSS total score (r=0.57, p<0.001)(Ta-
ble 4). Factor 3 did not show significant correlation with any 
of the PANSS subscale scores (Table 4). The SOPS total score was 
significantly correlated with cognitive dysfunction (r=0.68, p< 
0.001), positive symptoms (r=0.49, p<0.005), negative symp-
toms (r=0.63, p<0.001), and PANSS total score (r=0.65, p< 
0.001).
DISCUSSION
Currently, the SIPS and CAARMS scales are utilized to di-
agnose prodromal syndrome for psychosis and to measure the 
severity of prodromal symptoms. The present study examined 
the reliability, concurrent validity, and factor structure of the 
Korean version of SIPS. In the SYC, 40 subjects diagnosed as 
prodromal were closely monitored for more than 1 year. Of 
these 40 subjects, 12.5% developed psychotic disorders. Alth-
Table 2. Item distribution of the Scale of Prodromal Symptoms in the first evaluation (N=40)
Mean SD Range 
Positive symptoms
P1. Unusual thought content/Delusional ideas 3.50   1.32 0-5
P2. Suspiciousness/Persecutory ideas 3.20   1.52 0-5
P3. Grandiosity 0.25   0.81 0-3
P4. Perceptual abnormalities/Hallucinations 1.90   1.74 0-5
P5. Disorganized communication 1.28   1.34 0-4
Negative symptoms
N1. Social anhedonia or withdrawal 2.40   1.03 1-5
N2. Avolition 2.23   0.97 1-4
N3. Decreased expression of emotion 1.30   1.11 0-3
N4. Decreased experience of emotions and self 1.58   1.10 0-5
N5. Decreased ideational richness 1.25   0.98 0-3
N6. Deterioration in role functioning 2.85   1.39 0-5
Disorganization symptoms
D1. Odd behavior or appearance 0.50   0.88 0-3
D2. Bizarre thinking 0.90   1.08 0-4
D3. Trouble with focus and attention 2.53   0.91 0-5
D4. Personal hygiene/Social attentiveness 0.63   0.87 0-3
General symptoms
G1. Sleep disturbance 1.98   1.49 0-4
G2. Dysphoric mood 3.23   1.07 0-5
G3. Motor disturbances 0.50   0.96 0-4
G4. Impaired tolerance to normal stress 2.80   1.04 0-5MH Jung et al. 
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ough previous studies have shown conversion rates to psycho-
sis of approximately 40-50%,
7,27 other studies with a greater 
number of participants have reported conversion rates of 10-
20%.
10,11,28,29 This is similar to the conversion rates seen in the 
present study.
The inter-rater reliability for the SOPS total score was 0.96, 
and those for all subscales (positive, negative, disorganization, 
and general symptoms) were above 0.80. These were within a 
good range and consistent with a previous report stating that 
excellent inter-rater reliability value is 0.95 for the total score 
and above 0.75 for all four subscales.
7 With regard to internal 
consistency, the Cronbach’s alpha coefficient for the SOPS to-
tal score and for negative symptoms was good (0.83 and 0.78, 
respectively), and the coefficients for the positive and disor-
ganization subscales were low but acceptable (all >0.5). The 
Cronbach’s alpha coefficient for the general symptoms sub-
scale was somewhat lower (0.48). Decrease internal consisten-
cy of the general symptoms subscale might be influenced by 
the composition with four item and relatively smaller sample 
size of the subject. The Cronbach’s alpha coefficient for the 
general symptoms subscale in the P3 study was low (0.574) 
similar to the present study. However, the value of the Cron-
bach’s alpha coefficient for the negative symptoms subscale 
was high and similar to the P3 results in Spain.
12 The SOPS 
was developed to define and rate the severity of the prodro-
mal state of psychosis and was designed using the PANSS, with 
modifications of the positive symptom scales.
8 The fact that 
the Korean version of the SOPS has good internal consisten-
cy for the negative symptoms subscale coincides with other re-
ports suggesting that the internal coherence of negative symp-
toms is better than that of other subscales among patients 
with schizophrenia examined using PANSS.
30,31
Similar to the previous studies,
12,32 results from the factor an-
alysis of our subjects identified three factors. However, wher-
eas a previous study classified the analysis into negative, gen-
eral, and positive symptoms,
32 here, Factor 1 was shown to be a 
Table 3. Promax rotated loadings of the Scale of Prodromal Symptoms (three-factor model)
Factor 1 Factor 2 Factor 3
N1. Social anhedonia or withdrawal 0.963
N2. Avolition 0.919
D2. Bizarre thinking 0.627
P4. Perceptual abnormalities/Hallucinations 0.523
N6. Deterioration in role functioning 0.448
N4. Decreased experience of emotions and self 0.388
N3. Decreased expression of emotion 0.351
D3. Trouble with focus and attention -0.332-
P2. Suspiciousness/Persecutory ideas 0.296
D1. Odd behavior or appearance 0.868
D4. Personal hygiene/Social attentiveness 0.733
P5. Disorganized communication 0.656
G3. Motor disturbances 0.454
G1. Sleep disturbance 0.410
P1. Unusual thought content/Delusional ideas 0.267
N5. Decreased ideational richness 0.759
G4. Impaired tolerance to normal stress 0.692
P3. Grandiosity 0.598
G2. Dysphoric mood 0.208
For greater clarity, primary loadings are shown
Table 4. Correlations between three factors of the SOPS and five 
factors of the PANSS (N=40)
PANSS
SOPS
Factor 1 Factor 2 Factor 3 Total
Cognitive dysfunction 0.61** 0.70** 0.07 0.68**
Excitement 0.28 0.29 0.05 0.30
Depression 0.24 0.36 0.08 0.32
Positive symptoms 0.43* 0.47* 0.14 0.49**
Negative symptoms 0.72** 0.51* -0.06 0.63**
Total 0.53** 0.57** 0.21 0.65**
*p<0.005 significant after Bonferroni correction, **p<0.001. SOPS: 
Scale of Prodromal Symptoms, PANSS: Positive and Negative Syn-
drome Scale262  Psychiatry Investig 2010;7:257-263
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comparatively homogeneous component for negative symp-
toms, and Factors 2 and 3 appeared to be relatively heteroge-
neous in this study. The homogeneity of the negative symptoms 
in prodromal subjects in this study is also similar to findings 
in other studies that used PANSS to evaluate patients with schizo-
phrenia, which have identified negative symptoms as the ma-
jor component.
33-35 However, the heterogeneity of the other two 
factors is thought to be due to the small sample size of this st-
udy (n=40), similar to that in the P3 study (n=30).
12 In addition 
to the small sample size, the different characteristics of partici-
pants resulted in a greater number of GRD subjects (15%) in 
this study compared with their proportion in other studies (5% 
in the PRIME study and 6.6% in the P3 study).
12,32 Five items 
of the negative symptoms (‘social anhedonia or withdrawal,’ 
‘avolition,’ ‘deterioration in role functioning,’ ‘decreased expe-
rience of emotions and self,’ and ‘decreased expression of emo-
tion’) were also included in Factor 1 in other studies. As ‘avo-
lition’ is the cardinal symptom among negative aspects in schi-
zophrenia, ‘it has regularly loaded heavily on Factor 1 among 
prodromal subjects.
A valid scale should be highly correlated with a different 
scale measuring the same phenomenon. However, because no 
Korean version of a scale designed to diagnose and evaluate pro-
drome exists as yet, correlations among the five factors (cogni-
tive, excitement, depression, positive, and negative) were eval-
uated using the Korean version of PANSS.
14 Factor 1 of the SO-
PS showed the strongest correlation with negative symptoms 
of PANSS (r=0.72, p<0.001). Factor 2 showed the strongest cor-
relation with cognitive dysfunction (r=0.70, p<0.001). Factor 
3 was not correlated with any factor of PANSS. Consequently, 
Factor 1, Factor 2, and Factor 3 are thought to reflect negative 
symptoms, cognitive dysfunction, and general symptoms (non-
specific symptoms), respectively.
The present study has some limitations. Most importantly, 
as this study utilized only prodromal subjects and did not in-
clude participants who failed to meet the criteria for psycho-
sis, it does not have predictive validity. However, the 14 sub-
jects who had high genetic risk and family histories of schizo-
phrenia but showed no significant decline in functioning did 
not develop any psychotic disorders as assessed by the SIPS. 
Based on this indirect evidence, the predictive validity of SIPS 
may be considered good. Second, the small sample size is an-
other limiting factor. The present results should be seen as pre-
liminary, and the findings should be replicated using more 
subjects evaluated by the Korean version of SIPS. However, 
one must consider the difficulty of gathering and monitoring pos-
sible prodromal subjects for more than 1 year in a single center.
Despite these limitations and the need for further research 
using factor analysis with more subjects, the Korean version of 
SIPS demonstrates adequate reliability and appears to be help-
ful in the diagnosis and evaluation of prodrome in Korea. The 
collection of data from larger sample sizes is required so that the 
SIPS can be widely and extensively used in prodrome research.
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